Search research articles
Contact Us
Filters
Showing results (231-240 of 308) with videos related to
Page
of 31
Sort By:
Stem Cells (Dayton, Ohio)
|
September 1, 1995
Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia
Y Y Lee, W S Kim, Y J Bang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATIENTS IN TAIWAN AND SOUTH KOREA
N Rajan, G Cuyun Carter, A Kaltenboeck, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 1998
Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II)
H T Kim, D K Kim, Y B Cho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas
Y H Kim, H S Lee, H-J Lee, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 10, 2012
Postoperative chemoradiotherapy for gallbladder cancer
K Kim, E K Chie, J-Y Jang, et al.
Cancer Research and Treatment
|
December 19, 2015
A Phase II Trial of UFT-E and Oral Leucovorin in Advanced Colorectal Cancer
W S Lee, K S Lee, K H Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2018
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Y-J Bang, Y-K Kang, M Ng, et al.
Cancer
|
January 3, 2001
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma
S M Bang, D S Heo, K H Lee, et al.
The Journal of Biological Chemistry
|
February 7, 1998
A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor
S G Choi, Y Yi, Y S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2002
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer
H M Chang, K H Jung, T-Y Kim, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 308) with videos related to
Sort By:
Page
of 31
Stem Cells (Dayton, Ohio)
|
September 1, 1995
Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia
Y Y Lee, W S Kim, Y J Bang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATIENTS IN TAIWAN AND SOUTH KOREA
N Rajan, G Cuyun Carter, A Kaltenboeck, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 1998
Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II)
H T Kim, D K Kim, Y B Cho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas
Y H Kim, H S Lee, H-J Lee, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 10, 2012
Postoperative chemoradiotherapy for gallbladder cancer
K Kim, E K Chie, J-Y Jang, et al.
Cancer Research and Treatment
|
December 19, 2015
A Phase II Trial of UFT-E and Oral Leucovorin in Advanced Colorectal Cancer
W S Lee, K S Lee, K H Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2018
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Y-J Bang, Y-K Kang, M Ng, et al.
Cancer
|
January 3, 2001
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma
S M Bang, D S Heo, K H Lee, et al.
The Journal of Biological Chemistry
|
February 7, 1998
A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor
S G Choi, Y Yi, Y S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2002
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer
H M Chang, K H Jung, T-Y Kim, et al.
Page
of 31